5187 CREATE MEDIC CO.,LTD. - Financial Results

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

5187

TSE Standard

CREATE MEDIC CO.,LTD.

1,196

JPY

+38

(+3.28%)

Feb 20, 3:30 pm JST

7.70

USD

Feb 20, 1:30 am EST

Result

PTS

outside of trading hours

1,194

Feb 20, 3:06 pm JST

Summary Chart Historical News Financial Result

Current Period Guidance

Annual

Result

Guidance History

Growth Rate

Profitability

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Dec, 2022	12,326	741	834	482	53.0	37	Feb 13, 2023	J-GAAP
Dec, 2023	12,585	803	872	154	16.9	37	Feb 14, 2024	J-GAAP
Dec, 2024	13,030	692	750	840	95.4	39	Feb 13, 2025	J-GAAP
Dec, 2025	13,617	1,005	988	713	84.3	45	Feb 13, 2026	J-GAAP
Dec, 2026 Guidance	13,960	1,060	1,070	750	89.4	47	Feb 13, 2026	J-GAAP
YoY	+2.5%	+5.5%	+8.3%	+5.2%	+6.2%

Revision Direction	Revision Date	Revenue	Operating Profit	Ordinary Profit	Net Profit	Revised Dividend	Accounting Standards
Dec, 2021	Feb 10, 2021	11,086	788	800	559	37	J-GAAP
	Oct 28, 2021	11,556	1,015	1,071	701	37	J-GAAP
Results	Feb 10, 2022	11,698	866	1,009	660	37	J-GAAP
Dec, 2022	Feb 10, 2022	Available in future release
Results	Feb 13, 2023
Dec, 2023	Feb 13, 2023
	Oct 31, 2023
Results	Feb 14, 2024
Dec, 2024	Feb 14, 2024
Results	Feb 13, 2025
Dec, 2025	Feb 13, 2025
	Jan 23, 2026
Results	Feb 13, 2026
Dec, 2026	Feb 13, 2026	13,960	1,060	1,070	750	47	J-GAAP

Fiscal Year	Revenue	YoY	Operating Profit	YoY	Ordinary Profit	YoY	Adj. EPS	YoY
Dec, 2001	7,700	+6.0	Available in future release
Dec, 2002	7,861	+2.1
Dec, 2003	8,072	+2.7
Dec, 2004	8,219	+1.8
Dec, 2005	8,488	+3.3
Dec, 2006	8,439	-0.6
Dec, 2007	8,878	+5.2
Dec, 2008	9,058	+2.0
Dec, 2009	9,017	-0.5
Dec, 2010	9,097	+0.9
Dec, 2011	9,325	+2.5
Dec, 2012	9,331	+0.1
Dec, 2013	9,880	+5.9
Dec, 2014	9,939	+0.6
Dec, 2015	9,650	-2.9
Dec, 2016	10,003	+3.7
Dec, 2017	10,393	+3.9
Dec, 2018	10,796	+3.9
Dec, 2019	10,843	+0.4
Dec, 2020	10,830	-0.1
Dec, 2021	11,698	+8.0
Dec, 2022	12,326	+5.4
Dec, 2023	12,585	+2.1
Dec, 2024	13,030	+3.5
Dec, 2025	13,617	+4.5
Dec, 2026 Guidance	13,960	+2.5	1,060	+5.5	1,070	+8.3	89.4	+6.0

Fiscal Year	Revenue	Operating Profit	Operating Profit Margin	ROE	ROA	Total Asset Turnover Ratio	Adj. EPS
Dec, 2024	13,030	692	5.31	5.47	4.27	0.66	95.4
Dec, 2025	13,617	1,005	7.38	4.44	3.55	0.68	84.3
Dec, 2026 Guidance	13,960	1,060	7.59	4.59	3.72	0.69	89.4

All-Time High

	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS
Record	13,617	1,562	1,575	957	98.2
Fiscal Year	Dec, 2025	Dec, 2005	Dec, 2005	Dec, 2005	Dec, 2005

First Half

Result

Guidance History

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Jan - Jun, 2023	6,025	335	371	316	34.8	17	Aug 4, 2023	J-GAAP
Jan - Jun, 2024	6,300	291	345	550	61.4	19	Aug 5, 2024	J-GAAP
Jan - Jun, 2025	6,564	548	525	412	48.4	17	Aug 5, 2025	J-GAAP
Jan - Jun, 2026 Guidance	6,630	510	510	357	42.6	20	Feb 13, 2026	J-GAAP
YoY	+1.0%	-6.9%	-2.9%	-13.3%	-11.9%

Revision Direction	Revision Date	Revenue	Operating Profit	Ordinary Profit	Net Profit	Revised Dividend	Accounting Standards
Jun, 2023	Feb 13, 2023	6,068	369	376	230	17	J-GAAP
Results	Aug 4, 2023	6,025	335	371	316	17	J-GAAP
Jun, 2024	Feb 14, 2024	Available in future release
Results	Aug 5, 2024
Jun, 2025	Feb 13, 2025
Results	Aug 5, 2025
Jun, 2026	Feb 13, 2026	6,630	510	510	357	20	J-GAAP

Cash Flow

Annual

Fiscal Year	Operating Profit	Fee Cash Flow	Operating Cash Flow	Investing Cash Flow	Financial Cash Flow	Cash & Equivalents	Cash Ratio	Accounting Standards
Dec, 2023	803	335	698	-363	-362	3,770	19.58	J-GAAP
Dec, 2024	692	2,519	2,249	270	-877	5,662	28.24	J-GAAP
Dec, 2025	1,005	-43	530	-573	-600	5,060	25.12	J-GAAP

Actual Performance and Financial Trends

Historical Performance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Dec, 2023	12,585	803	872	154	16.9	37	Feb 14, 2024	J-GAAP
Dec, 2024	13,030	692	750	840	95.4	39	Feb 13, 2025	J-GAAP
Dec, 2025	13,617	1,005	988	713	84.3	45	Feb 13, 2026	J-GAAP
YoY	+4.5%	+45.2%	+31.7%	-15.1%	-11.7%

Quarterly Results

Result

Growth Rate

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Jan - Mar, 2024	2,976	98	106	59	6.5	3.3	May 7, 2024	J-GAAP
Apr - Jun, 2024	3,324	193	239	491	54.8	5.8	Aug 5, 2024	J-GAAP
Jul - Sep, 2024	3,212	230	200	194	21.9	7.2	Oct 31, 2024	J-GAAP
Oct - Dec, 2024	3,518	171	205	96	10.9	4.9	Feb 13, 2025	J-GAAP
Jan - Mar, 2025	3,220	221	215	209	24.4	6.9	May 7, 2025	J-GAAP
Apr - Jun, 2025	3,344	327	310	203	23.8	9.8	Aug 5, 2025	J-GAAP
Jul - Sep, 2025	3,490	365	346	254	29.9	10.5	Oct 31, 2025	J-GAAP
Oct - Dec, 2025	3,563	92	117	47	5.6	2.6	Feb 13, 2026	J-GAAP
YoY	+1.3%	-46.2%	-42.9%	-51.0%	-49.1%

Fiscal Year	Revenue	YoY	Operating Profit	YoY	Ordinary Profit	YoY	Adj. EPS	YoY
Jan - Mar, 2021	2,581	+11.2	Available in future release
Apr - Jun, 2021	2,898	+5.0
Jul - Sep, 2021	2,852	+7.8
Oct - Dec, 2021	3,367	+8.5
Jan - Mar, 2022	2,892	+12.0
Apr - Jun, 2022	3,029	+4.5
Jul - Sep, 2022	3,126	+9.6
Oct - Dec, 2022	3,279	-2.6
Jan - Mar, 2023	2,870	-0.8
Apr - Jun, 2023	3,155	+4.2
Jul - Sep, 2023	3,143	+0.5
Oct - Dec, 2023	3,417	+4.2
Jan - Mar, 2024	2,976	+3.7
Apr - Jun, 2024	3,324	+5.4
Jul - Sep, 2024	3,212	+2.2
Oct - Dec, 2024	3,518	+3.0
Jan - Mar, 2025	3,220	+8.2
Apr - Jun, 2025	3,344	+0.6
Jul - Sep, 2025	3,490	+8.7
Oct - Dec, 2025	3,563	+1.3	92	-46.2	117	-42.9	5.6	-48.6

All-Time High Quarterly Results

	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS
Record	3,563	800	797	491	54.8
Fiscal Year	Dec, 2025	Dec, 2005	Dec, 2005	Jun, 2024	Jun, 2024

Key Balance Sheet Figures

Fiscal Year	BPS	Equity Ratio	Total Asset	Equity	Retained Earnings	Interest-Bearing Debt Ratio	Announce	Accounting Standards
Dec, 2023	1,641.59	77.6	19,258	14,944	10,586	0.05	Feb 14, 2024	J-GAAP
Dec, 2024	1,833.67	78.6	20,047	15,750	11,078	0.05	Feb 13, 2025	J-GAAP
Dec, 2025	1,947.68	81.1	20,143	16,331	11,476	0.05	Feb 13, 2026	J-GAAP

CREATE MEDIC CO.,LTD.(5187) Financial Results